<VariationArchive RecordType="classified" VariationID="1073957" VariationName="NC_000016.9:g.(?_28484798)_28497560del" VariationType="Deletion" Accession="VCV001073957" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2021-12-02" MostRecentSubmission="2021-12-02">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1057767" VariationID="1073957">
      <GeneList>
        <Gene Symbol="CLN3" FullName="CLN3 lysosomal/endosomal transmembrane protein, battenin" GeneID="1201" HGNC_ID="HGNC:2074" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>16p12.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="28466653" stop="28492082" display_start="28466653" display_stop="28492082" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="28488599" stop="28503622" display_start="28488599" display_stop="28503622" Strand="-" />
          </Location>
          <OMIM>607042</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000016.9:g.(?_28484798)_28497560del</Name>
      <VariantType>Deletion</VariantType>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.(?_28484798_28497560del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.(?_28484798_28497560del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.(?_28484798)_28497560del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.(?_28484798)_28497560del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000016.9:g.(?_28484798)_28497560del AND Neuronal ceroid lipofuscinosis" Accession="RCV001387100" Version="2">
        <ClassifiedConditionList TraitSetID="8888">
          <ClassifiedCondition DB="MedGen" ID="C0027877">Neuronal ceroid lipofuscinosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-09-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-09-09" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-12-02" MostRecentSubmission="2021-12-02">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">24154662</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26766544</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28041643</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28559085</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8888" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1409" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Ceroid storage disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Neuronal ceroid lipofuscinosis</ElementValue>
                <XRef ID="Neuronal+Ceroid+Lipofuscinosis/5192" DB="Genetic Alliance" />
                <XRef ID="MONDO:0016295" DB="MONDO" />
                <XRef ID="42012007" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10739" />
                <XRef ID="10739" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000509415" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520997" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500216" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509416" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520996" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000561937" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509800" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520979" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520995" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review">
                <ID Source="PubMed">19084560</ID>
              </Citation>
              <XRef ID="216" DB="Orphanet" />
              <XRef ID="79263" DB="Orphanet" />
              <XRef ID="C0027877" DB="MedGen" />
              <XRef ID="MONDO:0016295" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS256730" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3113271" SubmissionDate="2021-11-23" DateLastUpdated="2021-12-02" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="NM_001042432.1_16_Deletion (exons 10-16)_28484797_28497560|MedGen:C0027877" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001587613" DateUpdated="2021-12-02" DateCreated="2021-05-10" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-09-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28041643</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24154662</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26766544</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28559085</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exons 10-16 of the CLN3 gene. The 5' boundary is likely confined to intron 9. The 3' end of this event is unknown as it extends through the termination codon beyond the assayed region for this gene and may encompass additional genes. While this deletion is not anticipated to result in nonsense mediated decay, it is expected to create a truncated protein product or disrupt mRNA translation. This variant has been observed in individual(s) with clinical features of retinitis pigmentosa (Inivtae). In at least one individual the data is consistent with the variant being in trans (on the opposite chromosome) from a pathogenic variant. This variant disrupts the p.Arg405 amino acid residue in CLN3. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 28041643, 24154662, 26766544, 28559085). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CLN3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.(?_28484798)_28497560del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027877" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10689444</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3113271" TraitType="Disease" MappingType="XRef" MappingValue="C0027877" MappingRef="MedGen">
        <MedGen CUI="C0027877" Name="Neuronal ceroid lipofuscinosis" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

